Donald Trump announced Thursday in the Oval Office that he’s struck a deal with two major pharmaceutical companies, Eli Lilly and Novo Nordisk, to lower prices for their popular weight-loss drugs, a new generation of products known as GLP-1 receptor agonists. The drugs, including Ozempic and Mounjaro, have proven very effective in helping people lose the pounds.
The event had a scary moment, however, when a pharmaceutical executive appeared to lose consciousness, and Dr. Mehmet Oz, the administration’s Administrator of the Centers for Medicare & Medicaid Services (CMS), had to rush to his aid.
Watch:
OFFICIAL COLLAPSES NEXT TO TRUMP AT OVAL OFFICE EVENT
— NewsWire (@NewsWire_US) November 6, 2025
White House Press Secretary Karoline Leavitt later announced that the man – whose identity has been under dispute in the media – was…




